La maladie de Waldenström ou macroglobulinémie
- 31 May 2013
- journal article
- Published by Elsevier BV in Revue Francophone des Laboratoires
- Vol. 2013 (452), 73-82
- https://doi.org/10.1016/s1773-035x(13)72034-3
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Second malignancies among Waldenstrom macroglobulinemia patients: small samples and sparse dataAnnals of Oncology, 2011
- Risk of lymphoproliferative disorders among first-degree relatives of lymphoplasmacytic lymphoma/Waldenström macroglobulinemia patients: a population-based study in SwedenBlood, 2008
- Long-term Evaluation of Three Multiple-Case Waldenström Macroglobulinemia FamiliesClinical Cancer Research, 2007
- Origins of Waldenström's Macroglobulinemia: Does It Arise from an Unusual B-Cell Precursor?Clinical Lymphoma, 2005
- Despite apparent morphologic and immunophenotypic heterogeneity, Waldenstrom's macroglobulinemia is consistently composed of cells along a morphologic continuum of small lymphocytes, plasmacytoid lymphocytes, and plasma cellsSeminars in Oncology, 2003
- Immunophenotypic analysis of Waldenstrom's macroglobulinemiaSeminars in Oncology, 2003
- Typical Waldenstrom macroglobulinemia is derived from a B-cell arrested after cessation of somatic mutation but prior to isotype switch eventsBlood, 2002
- A Long-Term Study of Prognosis in Monoclonal Gammopathy of Undetermined SignificanceThe New England Journal of Medicine, 2002
- Waldenström's macroglobulinemia*Cancer, 1998
- Incipient myelomatosis or «essential« hyperglobulinemia with fibrinogenopenia — a new syndrome?Acta Medica Scandinavica, 1944